Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 31, Issue 1, 1992, Pages 76-78

  de Vos, Dick ^a   Slee, Peter H Th J ^b   Stevenson, Derek ^c   Briggs, Ray J ^c  

^a TEVA Pharmachemie   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; DRUG METABOLITE; TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SERUM;

ADULT; AGED; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HALF-LIFE; HUMAN; MIDDLE AGE; TAMOXIFEN;

EID: 0026488166     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00695998     Document Type: Article

References (19)

1. Studies in the metabolism and pharmacokinetics of tamoxifen in normal volunteers
2. Kinetics of tamoxifen inhibition of aryl-carbon hydroxylase activity of intestinal and hepatic microsomes from male rats
3. The bioavailability of tamoxifen: new findings and their clinical implications
4. The pharmacology and clinical uses of tamoxifen
5. Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma
6. The bioavailability of Tamoplex (tamoxifen): 2. A single dose cross-over study in healthy male volunteers
7. Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance
8. Identification of 4-hydroxy- N-desmethyltamoxifen as a metabolite of tamoxifen in human bile
9. Distribution of 4-hydroxy- N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment
10. Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide
11. Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients
12. Aminoglutethimide enzyme induction: pharmacological and endocrinological implications
13. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer
14. Influence of tamoxifen and its N-desmethyl and 4-hydroxy metabolites on rat liver microsomal enzymes
15. Potential role of tamoxifen in prevention of breast cancer
16. Serum concentrations of tamoxifen and major metabolite during long-term Nolvadex therapy, correlated with clinical response
17. Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen
18. A bioequivalence study of two preparations of tamoxifen after single doses
19. Determination of tamoxifen and five metabolites in plasma and urine